Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - NAVIDEA BIOPHARMACEUTICALS, INC. | v244019_8k.htm |
| EX-99.1 - EXHIBIT 99.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v244019_ex99-1.htm |
| EX-99.2 - EXHIBIT 99.2 - NAVIDEA BIOPHARMACEUTICALS, INC. | v244019_ex99-2.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Neoprobe Corporation
Dublin, Ohio
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 33-81410, 333-05143, 333-119219, 333-130636, 333-130640, 333-153110, and 333-158323) of Neoprobe Corporation of our report dated March 16, 2011, except for Note 2 which is as of December 30, 2011, relating to the consolidated financial statements, which appears in this Form 8-K.
/s/ BDO USA, LLP
Chicago, Illinois
December 30, 2011